echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Deaths from unexplained kidney disease rose to 178 in Indonesia

    Deaths from unexplained kidney disease rose to 178 in Indonesia

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Indonesian Health Minister Budi Gunadi Sadikin reported in Jakarta on the 2nd that the number of cases of unexplained kidney disease reported in the country has increased to 325, of which 178 deaths
    Sadikin said Indonesia has reported cases of unexplained kidney disease from 27 provinces across the country, with the capital Jakarta having the largest number, followed by West Java, Banten and East Java
    Among the cases, 244 were children under 5 years old, accounting for more than 75%; The number of children aged 6 to 10 years was 42
    Indonesia began to have cases of unexplained kidney disease with a high fatality rate in January this year, and by August the sharp increase in the number of cases had attracted the attention of the
    country's health authorities and society.
    In October, Indonesia's Ministry of Health set up a special investigation team composed of experts from the Paediatric Association, hospital doctors and forensic laboratories to conduct an in-depth investigation
    In some cases, it was found that some patients were taking syrup drugs with excessive diethylene glycol and ethylene glycol
    Subsequently, the Indonesian Food and Drug Administration conducted sampling tests on syrup drugs in the country and showed that the content of diethylene glycol and ethylene glycol in a variety of syrup drugs exceeded the standard
    Indonesia's Ministry of Health has asked all health agencies and pharmacies in the country to temporarily stop prescribing or supplying liquid or syrup medications
    Sadikin said the measure had resulted in "a significant reduction in the number of new patients admitted to hospital for acute kidney disease.
    Penny, head of the Indonesian Food and Drug Administration, revealed in the country's parliament on the same day that there are loopholes
    in the import of raw materials for Indonesian pharmaceutical companies that can evade the supervision and inspection of drug regulatory authorities.
    She said that relevant regulations will be introduced to prevent loopholes, and called for severe punishment of illegal pharmaceutical companies and those responsible
    Two days earlier, the Indonesian Food and Drug Administration had revoked the production and operation licenses of two Indonesian local pharmaceutical companies, citing the use of substandard raw materials, undeclared changes in drug ingredients, and excessive consumption of some raw materials
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.